Breast MRI using a high-relaxivity contrast agent: an overview.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21427349.
- Also identified by DOI 10.2214/AJR.10.4974.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this article is to review the use of gadobenate dimeglumine, a high-relaxivity gadolinium-based contrast material, for breast MRI. Thanks to its high relaxivity, gadobenate dimeglumine offers valuable advantages in terms of lesion conspicuity, detection rate, and sensitivity for malignant breast lesions. However, a higher enhancement of benign lesions should be taken into account to avoid reduced specificity.
Medical subject headings
- Breast Neoplasms
- Contrast Media
- Magnetic Resonance Imaging
- Meglumine
- Organometallic Compounds